The effectiveness of physical activity in cardiorehabilitation-Reference-Cited by-同舟云学术

The effectiveness of physical activity in cardiorehabilitation

Published:2022-04-30 Issue:1 Volume:12 Page:37-46
ISSN:2587-9014
Container-title:Sports medicine: research and practice
language:
Short-container-title:jour

Author:

Yakovlev M. Yu.¹^ORCID,Lebedeva O. D.¹^ORCID,Vladimirsky V. E.²,Vladimirsky E. V.²^ORCID,Lunina A. N.²

Affiliation:

1. Federal State Budgetary Institution “National Medical Research Center of Rehabilitation and Balneology” of the Ministry of Health of the Russian Federation

2. Perm State Medical University named after Academician E. A. Wagner

Abstract

The review shows that the molecular mechanisms initiated by physical exertion underlie the multifactorial influence of the latter on the function of the cardiovascular system and the course of cardiac diseases. Exercise is an important component of the therapeutic treatment in patients with cardiovascular diseases, which is confirmed by the results of a metaanalysis that included 63 studies that were associated with various forms of aerobic exercise of different intensity (from 50 to 95 % VO2) for 1 to 47 months, which showed that exercise-based CR improves cardiovascular function. Knowledge of the molecular basis of the impact of physical activity makes it possible to use biochemical markers to assess the effectiveness of rehabilitation programs.

Publisher

National Alliance of Medicine and Sports - Healthy Generation

Reference63 articles.

1. Thomas R.J., King M., Lui K., Oldridge N., Pina I.L., Spertus J. AACVPR/ACC/AHA 2007 Performance Measures on Cardiac Rehabilitation for Referral to and Delivery of Cardiac Rehabilitation/Secondary Prevention Services. J. Cardiopulm. Rehabil. Prev 2007;27(5):260–290. https://doi.org/10.1097/01.hcr.0000291295.24776.7b

2. Piepoli M.F., Corra U., Benzer W., Bjarnason-Wehrens B., Dendale P., Gaitaetal D., et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur. J. Cardiovasc. 2010;17(1):1–17. https://doi.org/10.1097/hjr.0b013e3283313592

3. Ismaylov I. S., Mamedyarova I. A., Baranov A.V., Mustafaev R. D., Lebedeva O. D., Achilov A. A. Combined use of kineso- and laser therapy in the correction of regional hemodynamic disorders in dilated cardiomyopathy. Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul’tury. 2020;97(5):13–21 (In Russ.). https://doi.org/10.17116/kurort20209705113

4. Corbalan R., Bassand J.P., Illingworth L., Kayani G., Pieper K.S., Ambrosio G., et al. Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the garfield-af registry. JAMA Cardiology. 2019;4(6):526–548. https://doi.org/10.1001/jamacardio.2018.4729

5. Haas S., Cate H.T., Accetta G., Bassand J.P., Kayani G., Kakkar A.K., et al. Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the garfield-af registry. PLoSONE. 2016;11(10):e0164076. https://doi.org/10.1371/journal.pone.0164076